Sensible Biotechnologies raised €42M in a funding round in Oct 2026. The company is based in Oxford, UK. Investors in the round: Backed VC, Blueyard Capital, Civilization Ventures and 10 others. Data as of 9 Oct 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
